{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:44:32Z","timestamp":1787003072360,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The National Key Research and Development Program of Chin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70798-1","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:22:27Z","timestamp":1774286547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RFC4 drives temozolomide resistance in glioblastoma by activating STK38-BECN1-dependent autophagy"],"prefix":"10.1038","volume":"17","author":[{"given":"Min","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu-Jing","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-6773","authenticated-orcid":false,"given":"Mei-Hua","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-911X","authenticated-orcid":false,"given":"Han-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philipe","family":"Hugnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9325-3194","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8150-5486","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"70798_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"BM Alexander","year":"2017","unstructured":"Alexander, B. M. & Cloughesy, T. F. Adult glioblastoma. J. Clin. Oncol. 35, 2402\u20132409 (2017).","journal-title":"J. Clin. Oncol."},{"key":"70798_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","volume":"14","author":"R Chen","year":"2017","unstructured":"Chen, R., Smith-Cohn, M., Cohen, A. L. & Colman, H. Glioma subclassifications and their clinical significance. NeuroTherapeutics 14, 284\u2013297 (2017).","journal-title":"NeuroTherapeutics"},{"key":"70798_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom, Q. T. et al. The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol. 16, 896\u2013913 (2014).","journal-title":"Neuro Oncol."},{"key":"70798_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05373-4","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat. Commun. 9, 2949 (2018).","journal-title":"Nat. Commun."},{"key":"70798_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.15252\/emmm.201302627","volume":"6","author":"SK Carlsson","year":"2014","unstructured":"Carlsson, S. K., Brothers, S. P. & Wahlestedt, C. Emerging treatment strategies for glioblastoma multiforme. EMBO Mol. Med. 6, 1359\u20131370 (2014).","journal-title":"EMBO Mol. Med."},{"key":"70798_CR6","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/neuonc\/noy016","volume":"20","author":"S Choi","year":"2018","unstructured":"Choi, S. et al. Temozolomide-associated hypermutation in gliomas. Neuro Oncol. 20, 1300\u20131309 (2018).","journal-title":"Neuro Oncol."},{"key":"70798_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.molmed.2023.01.002","volume":"29","author":"KD Pawlowski","year":"2023","unstructured":"Pawlowski, K. D., Duffy, J. T., Babak, M. V. & Balyasnikova, I. V. Modeling glioblastoma complexity with organoids for personalized treatments. Trends Mol. Med. 29, 282\u2013296 (2023).","journal-title":"Trends Mol. Med."},{"key":"70798_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2017.10.017","volume":"184","author":"S Hombach-Klonisch","year":"2018","unstructured":"Hombach-Klonisch, S. et al. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response. Pharm. Ther. 184, 13\u201341 (2018).","journal-title":"Pharm. Ther."},{"key":"70798_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113740","volume":"155","author":"M Sanati","year":"2022","unstructured":"Sanati, M. et al. Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation. Biomed. Pharmacother. 155, 113740 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"70798_CR10","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1080\/15548627.2020.1816343","volume":"17","author":"I Compter","year":"2021","unstructured":"Compter, I. et al. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy 17, 2604\u20132612 (2021).","journal-title":"Autophagy"},{"key":"70798_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li, X., He, S. & Ma, B. Autophagy and autophagy-related proteins in cancer. Mol. Cancer 19, 12 (2020).","journal-title":"Mol. Cancer"},{"key":"70798_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D. J. et al. Autophagy in major human diseases. Embo J. 40, e108863 (2021).","journal-title":"Embo J."},{"key":"70798_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23923-1","volume":"12","author":"F Hu","year":"2021","unstructured":"Hu, F. et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat. Commun. 12, 3651 (2021).","journal-title":"Nat. Commun."},{"key":"70798_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.ccell.2022.08.014","volume":"40","author":"A Chryplewicz","year":"2022","unstructured":"Chryplewicz, A. et al. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity. Cancer Cell 40, 1111\u20131127.e1119 (2022).","journal-title":"Cancer Cell"},{"key":"70798_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-018-0618-0","volume":"11","author":"H Li","year":"2018","unstructured":"Li, H. et al. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3\/Bcl2 signaling pathway. J. Hematol. Oncol. 11, 70 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"70798_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02988-8","volume":"11","author":"EJ Yun","year":"2020","unstructured":"Yun, E. J., Kim, S., Hsieh, J. T. & Baek, S. T. Wnt\/\u03b2-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma. Cell Death Dis. 11, 771 (2020).","journal-title":"Cell Death Dis."},{"key":"70798_CR17","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1158\/1078-0432.CCR-18-3735","volume":"25","author":"XC Wang","year":"2019","unstructured":"Wang, X. C. et al. Genome-wide RNAi screening identifies RFC4 as a factor that mediates radioresistance in colorectal cancer by facilitating nonhomologous end joining Repair. Clin. Cancer Res. 25, 4567\u20134579 (2019).","journal-title":"Clin. Cancer Res."},{"key":"70798_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02630-8","volume":"20","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker. BMC Med. 20, 437 (2022).","journal-title":"BMC Med."},{"key":"70798_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0320-0","volume":"12","author":"J Xiang","year":"2014","unstructured":"Xiang, J. et al. Levels of human replication factor C4, a clamp loader, correlate with tumor progression and predict the prognosis for colorectal cancer. J. Transl. Med. 12, 320 (2014).","journal-title":"J. Transl. Med."},{"key":"70798_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22971-x","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. An RFC4\/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness. Nat. Commun. 12, 2693 (2021).","journal-title":"Nat. Commun."},{"key":"70798_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70798_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948150","volume":"20","author":"AP Martin","year":"2019","unstructured":"Martin, A. P. et al. STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes. EMBO Rep. 20, e48150 (2019).","journal-title":"EMBO Rep."},{"key":"70798_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/15548627.2015.1135283","volume":"12","author":"C Joffre","year":"2016","unstructured":"Joffre, C., Codogno, P., Fanto, M., Hergovich, A. & Camonis, J. STK38 at the crossroad between autophagy and apoptosis. Autophagy 12, 594\u2013595 (2016).","journal-title":"Autophagy"},{"key":"70798_CR24","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.cub.2015.08.031","volume":"25","author":"C Joffre","year":"2015","unstructured":"Joffre, C. et al. The pro-apoptotic STK38 kinase is a new beclin1 partner positively regulating autophagy. Curr. Biol. 25, 2479\u20132492 (2015).","journal-title":"Curr. Biol."},{"key":"70798_CR25","doi-asserted-by":"publisher","unstructured":"Fukasawa, T. et al. The role of mammalian STK38 in DNA damage response and targeting for radio-sensitization. Cancers 15, https:\/\/doi.org\/10.3390\/cancers15072054 (2023).","DOI":"10.3390\/cancers15072054"},{"key":"70798_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10495-018-1480-9","volume":"23","author":"MA Taylor","year":"2018","unstructured":"Taylor, M. A., Das, B. C. & Ray, S. K. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis 23, 563\u2013575 (2018).","journal-title":"Apoptosis"},{"key":"70798_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","volume":"58","author":"S Jiapaer","year":"2018","unstructured":"Jiapaer, S., Furuta, T., Tanaka, S., Kitabayashi, T. & Nakada, M. Potential strategies overcoming the temozolomide resistance for glioblastoma. Neurol. Med. Chir. 58, 405\u2013421 (2018).","journal-title":"Neurol. Med. Chir."},{"key":"70798_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-022-02291-8","volume":"41","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J. Exp. Clin. Cancer Res. 41, 74 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"70798_CR29","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1080\/15548627.2018.1504716","volume":"14","author":"BW Kim","year":"2018","unstructured":"Kim, B. W. et al. The C-terminal region of ATG101 bridges ULK1 and PtdIns3K complex in autophagy initiation. Autophagy 14, 2104\u20132116 (2018).","journal-title":"Autophagy"},{"key":"70798_CR30","doi-asserted-by":"publisher","first-page":"33847","DOI":"10.1074\/jbc.274.48.33847","volume":"274","author":"TA Millward","year":"1999","unstructured":"Millward, T. A., Hess, D. & Hemmings, B. A. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J. Biol. Chem. 274, 33847\u201333850 (1999).","journal-title":"J. Biol. Chem."},{"key":"70798_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-021-00855-2","volume":"7","author":"QJ Gai","year":"2022","unstructured":"Gai, Q. J. et al. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma. Signal Transduct. Target Ther. 7, 33 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"70798_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir, H., Robinson, J. T. & Mesirov, J. P. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178\u2013192 (2013).","journal-title":"Brief. Bioinform."},{"key":"70798_CR33","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute, I. et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 52, D174\u2013d182 (2024).","journal-title":"Nucleic Acids Res."},{"key":"70798_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41392-025-02309-5","volume":"10","author":"C Li","year":"2025","unstructured":"Li, C. et al. Aberrant Notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma. Signal Transduct. Target Ther. 10, 233 (2025).","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70798-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:36:29Z","timestamp":1778711789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70798-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70798"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70798-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6854944\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4348"}}